Status:
COMPLETED
Validation of a New Methodology for Mapping the Human Blood-Retinal Barrier Function
Lead Sponsor:
Association for Innovation and Biomedical Research on Light and Image
Conditions:
Age-Related Maculopathy
Diabetic Macular Edema
Eligibility:
All Genders
18+ years
Brief Summary
To validate a new methodology, named Retinal Leakage Analysis (RLA), for mapping the human Blood-Retinal Barrier (BRB) function, in the clinical practice.
Eligibility Criteria
Inclusion
- Patients diagnosed with AMD, or
- Patients diagnosed with DME
- Age over 18 years
- Inform consent
Exclusion
- Cataract or other eye disease that may interfere with fundus examinations
- Glaucoma
- Dilatation of the pupil \< 5 mm
Key Trial Info
Start Date :
March 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2010
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT00759044
Start Date
March 1 2008
End Date
October 1 2010
Last Update
October 15 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
AIBILI Clinical Trial Center
Coimbra, Coimbra District, Portugal, 3000-548